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Abstract
Background: Intestinal schistosomiasis is often widespread among the populations living around Lake Victoria and
on its islands. The Sesse Island group (containing some 84 islands), however, is typically assumed to be a low
prevalence zone, with limited transmission, but has never been surveyed in detail. Here, we present a rapid
mapping assessment, bringing together snail and parasite information, at 23 sites for the presence of intermediate
host snails and at 61 sites for the prevalence of intestinal schistosomiasis in school-aged children (N = 905). Two
different diagnostic tools were used and compared at 45 of these sites: Kato-Katz thick faecal smears and
circulating cathodic antigen (CCA) urine dipsticks.
Results: Biomphalaria snails were found at 11 sites but in low numbers; none was found shedding schistosome
cercariae. At 22 out of the 45 sites, local prevalence by urine and/or stool diagnostics was in excess of 50%,
although mean prevalence of intestinal schistosomiasis overall was 34.6% (95% confidence intervals (CI) = 31.0-
38.3%) by Kato-Katz and 46.5% (95% CI = 42.7-50.4%) by CCA if ‘trace’ reactions were considered infection-positive
(if considered infection-negative, mean prevalence was 28.1% (95% CI = 24.7-31.7%)). Diagnostic congruence
between CCA and Kato-Katz was poor and significant discordance in estimated prevalence by location was found,
with each often inferring different mass drug administration regimes.
Conclusions: Accurate estimation of schistosome prevalence is important for determining present and future
treatment needs with praziquantel; the wide range of schistosome prevalence across the Sesse Island group
requires a treatment regime largely tailored to each island. In high prevalence locations, further malacological
sampling is required to confirm the extent of local transmission, especially on the northern islands within the
group. The observation that different diagnostic tests can provide varying results in terms of estimating prevalence
by location, and hence change treatment recommendations, suggests that care must be taken in interpreting raw
prevalence data. In particular, further research into the reasons for the differences in the poorer performance of the
CCA test should be pursued.
Background
In Uganda, intestinal schistosomiasis, caused by the trema-
tode parasite Schistosoma mansoni, continues to be one of
the most important and widespread of the neglected tropi-
cal diseases. Its effects are particularly strongly felt in the
many communities living around East Africa’s Great
Lakes, such as the shoreline of Lake Victoria. The distribu-
tion of the disease is determined, to a large extent, by the
presence or absence of Biomphalaria snails, which act as
the parasite’s intermediate host. However, communities in
Lake Victoria have been shown to be highly motile, mean-
ing that a child may be examined for infection at a loca-
tion other than where the infection was obtained. This
emphasises the importance of combining malacological
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rapid mapping.
Traditional diagnostics used for assessment of schisto-
some prevalence have relied on stool microscopy, and
most commonly, Kato-Katz thick smears. Using stool
samples, Lot Quality Assurance Sampling has been
tested in Uganda as a cost-effective and rapid sampling
method [1]. However, slide preparation is still time-con-
suming, egg identification requires training and it can
be difficult to obtain stool samples on demand, espe-
cially if survey time constraints exist. As an alternative,
rapid diagnostic tests have been developed to combat
these issues for disease surveillance [2,3]. For example,
the circulating cathodic antigen (CCA) test (Rapid Med-
ical Diagnostics, Pretoria, South Africa) uses a drop of
urine on a lateral flow immuno-chromatographic strip
to detect the presence of adult worm infection, and has
been successfully tested, in its current formulation, in a
highly endemic setting [4]. However, its diagnostic cap-
ability has never been examined in a region where the
prevalence of intestinal schistosomiasis is suspected to
be lower, and infections of more variable intensities.
To combat schistosomiasis in this region, the govern-
ment of Uganda, with external support, has invested
heavily in a national control programme, which has
been run by the Vector Control Division (VCD) of the
Ministry of Health (with initial support from the Schis-
tosomiasis Control Initiative [SCI] and ongoing funding
from RTI International) since 2003 [5,6]. Treatment is
largely rolled out through schools, with drug administra-
tion intervals determined by prevalence of the disease
[7], but there is also presumptive treatment in commu-
nities considered at high risk. Until recently, the Sesse
Islands were not considered high priority for receiving
treatment, however, previous studies have shown that
there is significant heterogeneity in schistosomiasis pre-
valence across the shoreline of Lake Victoria [8]; the
Sesse Islands, comprising approximately 9000 km
2 of
land area over 84 main islands with an estimated popu-
lation of 44,000 people in 2006, provide an especial
challenge in this regard [9]. As such, local-scale map-
ping is required for accurate determination of a particu-
lar locality’s drug needs.
Our study therefore attempted to make a rapid map-
ping assessment of intestinal schistosomiasis on the Sesse
Islands and at the same time we compared the diagnostic
performance of CCA urine dipsticks with duplicate Kato-
Katz thick smears from a single stool (attempts were also
made to arbitrate findings against SEA-ELISA serological
testing). To assess local transmission, we undertook
malacological surveys, where possible, to clarify relation-
ships between disease point prevalence.
Results
The malacological surveys of the islands revealed low
abundance of Biomphalaria in most of the locations
examined (Figure 1a); only one marsh habitat site was
found, whereas all the rest were in Lake Victoria proper.
On the basis of shell morphology, the Biomphalaria
from the marsh site (site 38) were putatively identified
as B. sudanica, whereas all the other Biomphalaria
observed on this survey were identified as B. choanom-
phala.D N As e q u e n c i n go ft h e‘Folmer’ fragment of the
COI gene of 9 individuals (1 from site 41, 5 from site 38
and 3 from site 37; see Figure 1a) revealed five unique
haplotypes (labelled H171-H175; Genbank acquisition
numbers HM768902-HM768906), with no cross-over
between the populations. Although this is a high level of
diversity, divergence was low, with only 0.7% genetic
distance across the five haplotypes; this is consistent
with on-going molecular research on Biomphalaria
from elsewhere in Lake Victoria, which suggests that B.
choanomphala and B. sudanica should be considered
examples of ecophenotypic variation within a single spe-
cies or species complex.
None of the snails collected during the surveys were
found to be shedding S. mansoni cercariae. Rather sur-
prisingly, B. choanomphala could be found on rocky
and exposed shorelines, on the undersides of pebbles
and boulders, and were not restricted to weedy/muddy
shorelines as previously thought.
For the parasitological survey, 61 sites were visited in
total, and 45 were surveyed using both Kato-Katz and
CCA urine lateral flow tests (Figure 1a) with further
testing at five of these sites using SEA-ELISA kits. Over-
all prevalence of intestinal schistosomiasis, as observed
via positive Kato-Katz thick smears, was 31.4% (95%
confidence intervals [CI] = 28.4-34.5%; number of chil-
dren surveyed [N] = 905). For the 45 sites surveyed by
multiple diagnostics, prevalence by Kato-Katz thick
smear was 34.6% (95% CI = 31.0-38.3%; N = 683); when
measured by CCA urine lateral flow test, it was 46.5%
(95% CI = 42.7-50.4%; N = 666). This was when ‘trace’
calls were considered infection-positive, as per the man-
ufacturer’s instructions. To compare with previous CCA
efficacy studies, the prevalence was also calculated for
when ‘trace’ calls were considered negative, and in this
case, the value was 28.1% (95% CI = 24.7-31.7%; N =
666). Prevalence ranged widely across the islands, with
high prevalence (> 50%) localities predominant in the
northern islands of Bufumira sub-county (Figure 1b). A
full list of the schools visited, with their geographical
coordinates, number of children surveyed and preva-
lence by both Kato-Katz thick smear and CCA test, can
be found in Table 1.
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and SEA-ELISA, overall prevalence by each of the three
diagnostics was 11.7% (95% CI = 5.8-20.6%; N = 85),
22.1 (95% CI = 14.6-31.3%; N = 104) and 39.2% (95% CI
= 29.7-49.4%; N = 102) respectively [Table 2]. In all
sites bar one, SEA-ELISA resulted in the highest preva-
lence. Prevalence when CCA traces were considered
infection-positive varied widely compared to when they
were calculated as being infection-negative.
The relationship between Kato-Katz thick smear result
and CCA was investigated further by directly comparing
the CCA test result of children with a particular faecal egg
per gram (EPG) value (Figure 2). A large number (139 out
of 413) of children with no eggs observed in microscopic
examination of their stool had positive or ‘trace’ CCA
tests; similarly, an individual with an egg count as high as
1284 EPG had a negative CCA result. These outliers can
also be seen in the box plot measuring CCA test score
against EPG directly (Figure 3). Accordingly, diagnostic
scores were low when comparing the CCA tests, calcu-
lated both for ‘trace’ being positive as well as ‘trace’ being
negative, against Kato-Katz values (Table 3).
Prevalence at each school as determined by Kato-Katz
and by CCA urine test was directly compared with a
scatter plot, which further compared the difference in
prevalence value as obtained when ‘trace’ calls were
infection-positive and when they were infection-negative
(Figure 4). As treatment regimes are based on preva-
lence categories, these were also included on the figure.
The lines marked ‘A’ and ‘B’ refer to cases whereby
downgrading ‘trace’ calls from positive to negative drops
that particular school under 50% prevalence, thus chan-
ging its recommended treatment regime. For ‘A’,t h e
Kato-Katz prevalence is below 50%, thus agreeing with
the ‘trace’ as negative CCA test result; however, for ‘B’,
Kato-Katz prevalence was above 50%. Table 4 shows a
breakdown of the recommended treatment regimes for
each location, based on these surveys, and further
demonstrates the number of sites that would change
treatment regimes either between the Kato-Katz and
CCA results, or even between calling ‘trace’ results as
positive and calling them as negative. It is of note that
in some low-to-moderate prevalence settings, CCA dip-
sticks have underestimated treatment needs by location,
Figure 1 Results of rapid malacological and parasitological mapping assessment of the Sesse Islands, Uganda, in January 2010. (a) 23
sites surveyed for Biomphalaria snails, with spots coloured by abundance. Site 38 had two habitat types: ‘a’ denotes a marsh habitat, where B.
sudanica snails were found, and ‘b’ denotes a lake habitat, where B. choanomphala were found. All other sites were lake habitats. (b) A total of
61 sites where school children were surveyed for intestinal schistosomiasis using Kato-Katz thick smears. Of these, 45 were investigated using
both Kato-Katz and CCA urine dipsticks. The remaining sites, where only Kato-Katz thick smears were used, are marked with ‘*’ and the results by
location will be presented elsewhere (here the data were only used for overall prevalence estimates). CCA ‘trace’ results were considered
infection-positive here. The location name, geographical coordinates and prevalence of schistosomiasis for each of the 45 sites is reported in
Table 1, along with prevalence if CCA ‘trace’ was considered infection-negative.
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Page 3 of 11Table 1 Map ID number, GPS coordinates, village name, subcounty and prevalence of intestinal schistosomiasis as
determined by Kato-Katz and CCA tests. ‘N’ = number of children surveyed; ‘CI’ = confidence intervals
Map ID
(GPS coordinates)
Village Subcounty Prevalence by Kato-Katz Prevalence by CCA
(N, 95% CI) ’Trace’ = pos.
(N, 95% CI)
’Trace’ = neg.
(N, 95% CI)
1
(S0.22048, E32.07748)
Kibanga Mugoye 68.8
(16, 41.3-89.0)
100.0
(16, 79.4-100.0)
68.8
(16, 41.3-89.0)
2
(S0.22820, E32.10802)
Buziga Mugoye 46.2
(13, 19.2-74.9)
56.3
(16, 29.9-80.2)
25.0
(16, 7.3-52.4)
3
(S0.22986, E32.14310)
Bungo Mugoye 0.0
(12, 0.0-26.5)
15.4
(13, 1.9-45.4)
0.0
(13, 0.0-24.7)
4
(S0.23807, E32.18468)
Kasekulo Mugoye 50.0
(16, 24.7-75.3)
62.5
(16, 35.4-84.8)
43.8
(16, 19.8-70.1)
5
(S0.31496, E32.19963)
Kagolomola Mugoye 14.3
(14, 1.8-42.8)
100.0
(14, 76.8-100.0)
50.0
(14, 23.0-77.0)
6
(S0.30533, E32.23756)
Kasenyi Mugoye 16.7
(12, 2.1-48.4)
13.3
(15, 1.7-40.5)
6.7
(15, 0.2-31.9)
7
(S.32837, E32.31014)
Mwena Mugoye 21.4
(14, 4.7-50.8)
28.6
(14, 8.4-58.1)
7.1
(14, 0.2-33.9)
8
(S0.36381, E32.29543)
Kaagonya Mugoye 25.0
(8, 3.2-65.1)
12.5
(8, 0.3-52.7)
12.5
(8, 0.3-52.7)
9
(S0.39600, E32.32784)
Kisujju Mugoye 28.6
(14, 8.4-58.1)
46.2
(13, 19.2-74.9)
46.2
(13, 19.2-74.9)
10
(S0.41439, E32.30922)
Kivunza Mugoye 77.8
(9, 40.0-97.2)
66.7
(9, 30.0-92.5)
66.7
(9, 30.0-92.5)
11
(S0.36485, E32.23876)
Njoga Mugoye 0.0
(14, 0.0-23.2)
100.0
(15, 78.2-100.0)
0.0
(15, 0.0-21.8)
12
(S0.33256, E32.18855)
Banga Mugoye 6.7
(15, 0.2-31.9)
11.8
(17, 1.5-36.4)
11.8
(17, 1.5-36.4)
13
(S0.32341, E32.14947)
Mutambala Mugoye 10.0
(10, 0.3-44.5)
0.0
(14, 0.0-23.2)
0.0
(14, 0.0-23.2)
14
(S0.26678, E32.07942)
Banda1 Mugoye 28.6
(14, 8.4-58.1)
64.3
(14, 35.1-87.2)
42.9
(14, 17.7-71.1)
15
(S0.24923, E32.06704)
Luku Mugoye 47.1
(17, 23.0-72.2)
58.8
(17, 32.9-81.6)
35.3
(17, 14.2-61.7)
16
(S0.19225, E32.25963)
Luwungulu Bufumira 30.8
(13, 9.1-61.4)
50.0
(14, 23.0-77.0)
21.4
(14, 4.7-50.8)
17
(S0.16808, E32.27124)
Kammesse Bufumira 73.3
(15, 44.9-92.2)
93.3
(15, 68.1-99.8)
66.7
(15, 38.4-88.2)
18
(S0.17993, E32.29384)
Kachanga Bufumira 75.0
(16, 47.6-92.7)
100.0
(15, 78.2-100.0)
73.3
(15, 44.9-92.2)
19
(S0.18954, E32.30225)
Kaaya Bufumira 66.7
(18, 41.0-86.7)
100.0
(15, 78.2-100.0)
60.0
(15, 32.3-83.7)
20
(S0.22574, E32.30759)
Kibibi Bufumira 57.1
(7, 18.4-90.1)
57.1
(7, 18.4-90.1)
42.9
(7, 9.9-81.6)
21
(S0.19813, E32.33113)
Misonzi Bufumira 46.9
(32, 29.1-65.3)
73.3
(15, 44.9-92.2)
53.3
(15, 26.6-78.7)
22
(S0.24036, E32.35637)
Bosa Bufumira 52.9
(17, 27.8-77.0)
71.4
(14, 41.9-91.6)
35.7
(14, 12.8-64.9)
23
(S0.25941, E32.39413)
Banda Bufumira 73.3
(15, 44.9-92.2)
93.3
(15, 68.1-99.8)
86.7
(15, 59.5-98.3)
24
(S0.26246, E32.42848)
Kitobo Bufumira 69.2
(26, 48.2-85.7)
80.0
(15, 51.9-95.7)
60.0
(15, 32.3-83.7)
25
(S0.34038, E32.48982)
Namasengere Bufumira 37.5
(16, 15.2-64.6)
92.9
(14, 66.1-99.8)
50.0
(14, 23.0-77.0)
26
(S0.37258, 32.47824)
Mukaka Bufumira 46.7
(15, 21.3-73.4)
33.3
(15, 11.8-61.6)
6.7
(15, 0.2-31.9)
27
(S0.40281, E32.40434)
Kaazi Bufumira 86.7
(15, 59.5-98.3)
80.0
(15, 51.9-95.7)
53.3
(15, 26.6-78.7)
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Page 4 of 11when compared to Kato-Katz examinations, resulting in
conflicting mass drug administration regimes.
Discussion
Mapping schistosomiasis in the Sesse Islands
Mapping this island group for schistosomiasis poses a
significant logistical challenge in terms of equipment
and resources as only the main island (Kalangala) is
directly accessible by ferry from the mainland, whilst all
the others are reachable by small boat access alone.
Many of the Sesse Islands, especially those in the south-
east, are remote and poorly served, yet are inhabited by
large numbers of people (and associated communities)
typically engaged in the Lake Victoria fishery. Our sur-
vey has shown that far from being a uniformly low
transmission zone, as had been assumed previously, the
Sesse Islands display significant heterogeneities in terms
o ft h ep r e v a l e n c eo fS. mansoni, with obvious implica-
tions for on-going treatment campaigns and revision of
general advice for tourists visiting these islands. Rather
surprisingly, the CCA urine lateral flow tests did not
perform as well in this putative low transmission setting,
in terms of diagnostic scores as compared to Kato-Katz
thick smears, as had been the case in other regions of
Lake Victoria where transmission was high [4].
The prevalence maps of the Sesse Islands clearly show
that the northern islands in the archipelago, in northern
Bufumira sub-county, appear a local hot spot for schis-
tosomiasis. Much of the rest of the archipelago, and
especially the southern and eastern out-lying islands,
have much lower prevalence of the disease; these areas
were also surveyed for snails, and Biomphalaria
Table 1 Map ID number, GPS coordinates, village name, subcounty and prevalence of intestinal schistosomiasis as
determined by Kato-Katz and CCA tests. ‘N’ = number of children surveyed; ‘CI’ = confidence intervals (Continued)
28
(S0.42411, E32.36667)
Kyankolokolo Bufumira 20.0
(15, 4.3-48.1)
6.7
(15, 0.2-31.9)
6.7
(15, 0.2-31.9)
29
(S0.43715, E32.35111)
Lwabaswa Mugoye 18.2
(11, 2.3-51.8)
84.6
(13, 54.6-98.1)
76.9
(13, 46.2-95.0)
30
(S0.45702, E32.32824)
Kasisa Mugoye 25.0
(12, 5.5-57.2)
45.5
(11, 16.7-76.6)
36.4
(11, 10.9-69.2)
31
(S0.36561, E32.41432)
Lulindi Bufumira 55.6
(18, 30.8-78.5)
66.7
(12, 34.9-90.1)
50.0
(12, 21.1-78.9)
32
(S0.33807, E32.37603)
Ssemawundo Bufumira 59.4
(32, 40.6-76.3)
46.7
(15, 21.3-73.4)
40.0
(15, 16.3-67.7)
33
(S0.22757, 32.55733)
Jaana Jaana 5.0
(20, 0.1-24.9)
8.7
(23, 1.1-28.0)
4.3
(23, 1.1-21.9)
34
(S0.33335, E32.56855)
Bubeke Jaana 23.1
(13, 5.0-53.8)
0.0
(16, 0.0-20.6)
0.0
(16, 0.0-20.6)
35
(S0.35153, E32.57128)
Buyange Kyamuswa 0.0
(17, 0.0-19.5)
6.3
(16, 0.2-30.2)
0.0
(16, 0.0-20.6)
36
(S0.37463, E32.51683)
Lwenabatwa Kyamuswa 10.0
(10, 0.3-44.5)
40.1
( 23, 19.7-61.5)
13.0
(23, 2.8-33.6)
37
(S0.48870, E32.44622)
Nakibanga Kyamuswa 26.7
(15, 7.8-55.1)
13.3
(15, 1.7-40.5)
13.3
(15, 1.7-40.5)
38
(S0.52895, E32.29731)
Mawala Mazinga 7.7
(13, 0.2-36.0)
20.0
(15, 4.3-48.1)
20.0
(15, 4.3-48.1)
39
(S0.64666, E32.35232)
Kuuye Mazinga 20.0
(20, 5.7-43.7)
25.0
(20, 8.7-49.1)
15.0
(20, 3.2-37.9)
40
(S0.67167, E32.32633)
Kachungwa Mazinga 10.0
(20, 1.2-31.7)
13.0
(23, 2.8-33.6)
4.3
(23, 0.1-21.9)
41
(S0.63200, E32.31278)
Kirugu Mazinga 14.3
(14, 1.8-42.8)
5.9
(17, 0.1-28.7)
5.9
(17, 0.1-28.7)
42
(S0.71890, E32.30853)
Nkose Mazinga 0.0
(13, 0.0-24.7)
15.4
(13, 1.9-45.4)
7.7
(13, 0.2-36.0)
43
(S0.73168, E32.26802)
Miyana Mazinga 12.5
(8, 0.3-52.7)
28.6
(7, 3.7-71.0)
0.0
(7, 0.0-41.0)
44
(S0.68592, E32.18170)
Lujjabwa Mazinga 0.0
(14, 0.0-23.2)
35.3
(17, 14.2-61.7)
0.0
(17, 0.0-19.5)
45
(S0.56909, E32.22253)
Butulume Mazinga 13.3
(15, 1.7-40.5)
26.7
(15, 7.8-55.1)
0.0
(15, 0.0-21.8)
TOTAL –– 34.6
(683, 31.0-38.3)
46.5
(666, 42.7-50.4)
28.1
(666, 24.7-31.7)
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Page 5 of 11Table 2 Prevalence of schistosomiasis comparing Kato-Katz diagnostic with CCA tests and SEA-ELISA
Site
(Map ID)
DIAGNOSTIC TEST
Kato-Katz CCA SEA-ELISA
N Infection
intensity
L/M/H
Prevalence
(95% CIs)
N Infection
intensity
tr/+/++/+++
Prevalence - trace
as positive
(95% CIs)
Prevalence - trace as
negative
(95% CIs)
N Infection
intensity
tr/+/++/+++
Prevalence
(95% CIs)
Butulume
(45)
15 2/0/0 13.3
(1.7-40.5)
15 4/0/0/0 26.7
(7.8-55.1)
0.0
(0.0-21.8)
15 3/0/0/0 20.0
(4.3-48.1)
Jaana
(33)
20 1/0/0 5.0
(0.1-24.9)
23 1/1/0/0 8.7
(1.1-28.0)
4.3
(0.1-21.9)
22 0/6/2/4 54.5
(32.2-75.6)
Kachungwa
(40)
20 2/0/0 10.0
(1.2-31.7)
23 2/1/0/0 13.0
(2.8-33.6)
4.3
(0.1-21.9)
23 2/1/4/2 39.1
(19.7-61.4)
Kuuye
(39)
20 3/1/0 20.0
(5.7-43.7)
20 2/2/1/0 25.0
(8.7-49.1)
15.0
(3.2-37.9)
20 1/1/3/1 30.0
(11.9-54.3)
Lwenabatwa
(36)
10 1/0/0 10.0
(0.3-44.5)
23 6/2/1/0 39.1
(19.7-61.5)
13.0
(2.8-33.6)
22 2/2/3/6 59.1
(36.4-79.3)
TOTAL 85 9/1/0 11.7
(5.8-20.6)
104 15/6/2/0 22.1
(14.6-31.3)
7.8
(3.3-14.6)
102 8/10/12/13 39.2
(29.7-49.4)
’Trace’ read for CCA tests considered both as positive and negative. ‘N’ refers to the number of children surveyed by each diagnostic; ‘L’ stands for ‘Light’
infection intensity (< 100 eggs per gram of faeces [epg]), ‘M’ corresponds to ‘Moderate’ infection intensity (≥100 < 400 epg) and ‘H’ refers to ‘Heavy’ infection
intensity (≥ 400 epg). ‘tr’ stands for trace reaction of CCA test, and ‘+’, ‘++’ and ‘+++’ stand for single, double and triple strength reactions, respectively.
Figure 2 Comparison of egg per gram (EPG) scores and corresponding CCA test result as ‘positive’, ‘trace’ or negative. (a) Number of
CCA tests for a particular EPG score, and the breakdown of the tests into ‘positive’, ‘trace’ and ‘negative’ results. (b) Breakdown of CCA test
results for schoolchildren who had zero S. mansoni eggs detected in their Kato-Katz thick smears.
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Unfortunately, owing to time and personnel constraints,
snail surveys were not undertaken in Bufumira sub-
county; therefore we cannot yet know whether the high
prevalence observed there could be maintained through
local transmission, or whether the children had acquired
their infections elsewhere. Previous demographic surveys
in Lake Victoria have revealed very high levels of itiner-
ancy among the communities living along the lakeshore;
in Kalangala District, in 2008, almost 60% of the 189
children surveyed had been born outside of the district,
and as far afield as Tanzania [8]. The World Health
Organization has put a large emphasis on the need to
create predictive maps, for example of expected schisto-
some distributions, but these need to be validated on
the ground; Bufumira sub-county would be a crucial
location for further malacological surveys in order to
better understand the relationship between prevalence
and snail distribution and thus create more accurate
predictive maps. Vector Control Division will shortly be
providing an updated atlas of the prevalence of intestinal
schistosomiasis across the shoreline of Lake Victoria
drawing further attention to disease heterogeneity at the
local level.
Diagnostic comparisons and differences
Across the district, a number of sites had significant dif-
ferences in the prevalence as ascertained by one diag-
nostic or another. For example, Site 11 would have been
considered high prevalence on the basis of CCA results,
and yet not a single positive Kato-Katz thick smear was
observed. Conversely, two sites would have been consid-
ered absent of S. mansoni had only CCA tests been
used, and yet had Kato-Katz prevalence of 23.1% and
10.0% respectively.
The variability of the CCA test in this setting is the
cause of some concern, and indeed the diagnostic scores
are generally lower than given in other studies [10-12].
Moreover, the results could be explained by the particu-
lar transmission dynamics of schistosomiasis in these
islands. As we have shown, in many localities in the
Sesse Islands there is a relative lack of intermediate host
snails, as compared to other parts of the Ugandan
shoreline. If the Sesse Islands themselves are not a high
transmission zone, children may only be exposed to the
parasite infrequently, resulting in long-term infection
from single or infrequent exposure event(s). As these
worms age, fecundity could decrease with senescence,
reducing egg output intensity and in this scenario, a
CCA test would be positive whereas the Kato-Katz thick
smear might not reveal eggs.
Another factor to consider is that the CCA test is
thought to be sensitive to differences in antigenicity of
the parasite populations [3,13]; it is plausible that
changes in parasite genotypes (and phenotypes) across
the lakeshore may result in altered performance of the
CCA test. Similarly, if exposure is low, the diversity of
the parasite genotypes present within an individual child
may also be lower than in other regions, which too
could alter the way in which the test reacts.
The SEA-ELISA results potentially reveal a further
complication; the effect of prior treatment. As the egg
antigens used in the ELISA may persist after the parasite
is eliminated, for example post-treatment with prazi-
quantel, individuals may test sera-positive despite not
having an active infection. In the Sesse Islands, while
treatment is far from ubiquitous, the district has been
involved in the national control programme since 2005,
and mass drug administration has been underway since
then, particularly on the main island. In this survey, 49
out of 226 children (21.7%) interviewed on site reported
having received praziquantel at some point. As such,
whereas SEA-ELISA testing is an extremely sensitive
Figure 3 Box plot of CCA test band strength against S.
mansoni egg per gram count. Egg count based on duplicate
Kato-Katz thick smear; indents in the boxes denote 95% CI.
Table 3 Diagnostic scores of CCA test against ‘gold
standard’ of double Kato-Katz smear
Trace call SS
(95% CIs)
SP
(95% CIs)
PPV
(95% CIs)
NPV
(95% CIs)
Positive 78.2
(72.1-83.5)
66.3
(61.7-70.8)
52.6
(46.9-58.2)
86.4
(82.4-89.9)
Negative 63.5
(56.6-69.9)
86.4
(82.9-89.5)
69.1
(62.1-75.5)
83.2
(79.5-86.5)
’Positive’ refers to ‘trace’ calls on the CCA test being considered positive,
whereas ‘Negative’ refers to counting ‘trace’ results as negative.
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un-surveyed area, its lack of discrimination between his-
torical and current infections make it unsuitable for
on-going monitoring, partic u l a r l yw h e r eat r e a t m e n t
programme is in place.
Implications for treatment recommendations
The main aim in measuring prevalence of schistosomiasis
in these various locations is to use the information to
provide recommendations to the Vector Control Divi-
sion’s Ministry of Health, to streamline the delivery of
praziquantel in their national treatment programme and
to maximise its therapeutic coverage across the disease
endemic landscape. Under-estimating the prevalence of
intestinal schistosomiasis by locality leads to incorrect
assessment of actual treatment needs, and since drug
resources are finite, medications could be reassigned to
other sites incorrectly. Conversely overestimating the
prevalence of the disease by site could lead to increased
drug wastage as treatments may be given to
patients when not actually needed, but ethically, over-
treatment is a more equitable position than omission of
treatment [14].
Here, we have shown that SEA-ELISA is likely to over-
estimate present treatment needs as past treatment his-
tory likely confounds this assay, particularly in areas
where mass drug distribution has taken place. However,
we also show that CCA tests can often inaccurately
Figure 4 Scatter plot of prevalence as determined by Kato-Katz against that determined by CCA test. ‘Trace’ result as negative is
compared to ‘trace’ result as positive. The graph area is shaded based on the WHO thresholds for different treatment recommendations. ‘A’
denotes a site where Kato-Katz and CCA (when ‘trace’ results are called negative) both show prevalence under 50%, but which rises to over 50%
if ‘trace’ CCA calls are considered positive. ‘B’ denotes a site where Kato-Katz and CCA results agree on a prevalence but only when CCA ‘trace’
results are considered positive; if considered negative, CCA result drops below 50%.
Table 4 Number of sites in each treatment strategy classification, based on different diagnostics
No treatment (prevalence < 10%) Single treatment (≥ 10-50%) Annual treatment (≥ 50%)
Kato-
Katz
CCA (trace =
positive)
CCA (trace =
negative)
Kato-
Katz
CCA (trace =
positive)
CCA (trace =
negative)
Kato-
Katz
CCA (trace =
positive)
CCA (trace =
negative)
Number of
sites
9 6 16 23 18 16 13 21 13
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Kato-Katz thick smears from a single stool sample. None-
theless, the need for mapping prevalence can bring for-
ward significant drug savings, as well as programmatic
costs when set across a 5-year period of intervention.
The Sesse Islands can be considered a further example of
where good baseline information is needed to guide sen-
sible decisions in meeting present and future local treat-
ment needs. In this setting, and as a rough
approximation, the raw costs of blanket annual mass
drug administration for 5 years could be estimated as US
$7593 (45 villages each having 250 children per village
with an average dose of 2.7 tablets of praziquantel per
child at US$0.05 per tablet). Simply by doing a local-scale
r a p i da s s e s s m e n ts u r v e ys u c ha st h i so n e ,c o s t so fd r u g
procurement can be more than halved. Based on Kato-
Katz prevalence, 13 schools require annual treatment; if
the other 32 are all given a single dose, the cost is now
US$3273.75, for the 5-year period. This value holds true
for if ‘trace’ CCA calls are considered negative, as well. If
‘trace’ is considered infection-positive, the amount
n e e d e dr i s e st oU S $ 4 3 5 3 . 7 5 ,b u tt h i si ss t i l lm u c hl e s s
than the cost of blanket annual treatment. Of course, this
does not take into account the cost of training, transport,
monitoring and other supplementary activities. Neverthe-
less the point stands: regardless of diagnostic technique,
implementing local-scale monitoring into control pro-
gramme surveys can greatly reduce the cost of the inter-
vention, by tailoring treatment regimes to local needs
especially from longer term perspectives and provide
evidence-based decision making.
As we have discussed, however, the difficulty lies with
determining exactly what local treatment needs actually
are, especially in the face of varying results from differ-
ent diagnostics. Here, more thematic research is needed,
for example in comparing the CCA tests against tripli-
cate Kato-Katz thick smears from successive stools, as a
more accurate ‘gold’ measure. Doing this could lead to a
correction factor for the CCA test, to be used in rapid
assessment settings where only single stool samples are
examined. Alternatively, other eggs in stool detection
methods could be explored, some of which have been
shown to be potentially more sensitive than triple Kato-
Katz thick smears for detecting parasite eggs [15,16].
However, all alternative methods should be field-tested
to determine efficacy and usability, even in remote set-
tings, before being widely recommended and scaled-up
for rapid mapping endeavours [17]. For the meantime,
we urge researchers to continue to test the CCA urine
lateral flow test alongside Kato-Katz thick smears, in dif-
ferent epidemiological settings which may later allow a
future meta-analysis of performance across transmission
landscapes. In addition, it would be useful to explore in
greater detail the effect of parasite genetic diversity on
the diagnostic sensitivity of CCA tests; as our knowledge
base grows regarding the molecular epidemiology of
S. mansoni in Lake Victoria, we may be better placed to
judge its effect on such diagnostic tools.
Conclusions
Here, we present the first comprehensive survey of intest-
inal schistosomiasis and intermediate host snails on the
Sesse Islands, in Lake Victoria. Long considered a low
priority for treatment interventions, we have shown that
in fact prevalence in some areas is very high, and cer-
tainly sufficient to merit on-going annual treatment. We
also demonstrate the need for more rigorous malacologi-
cal sampling across the archipelago, and particularly in
high prevalence environments. However, we also show
that treatment recommendations can vary depending on
the diagnostic test used; these differences will need to be
examined more closely to ensure that the efficacy and
efficiency of the control programme is maximised.
Methods
Malacological surveys
Snail surveys were undertaken in 23 locations around
the Sesse Islands in 2008 and 2010. Sampling was semi-
quantitative, with two collectors scooping for a period
of 20 min over an area of shoreline approximately 50 m
in length. Habitat type was noted, and a putative field
identification made of the Biomphalaria snails collected,
based on shell morphology. Water chemistry values,
such as pH, conductivity (μS) and total dissolved solutes
(TDS) were also taken. Geographical position (GPS
coordinates) of the site was recorded using a Garmin
GPS V® (Garmin (Europe) Ltd.; Southampton, UK).
DNA from 24 snails from four locations was extracted
using a standard CTAB and chloroform-isoamyl alcohol
methodology, with precipitation in 100% ethanol and final
rehydration in pure water. PCR amplifications were carried
out on a Veriti thermal cycler (Applied Biosystems Inc.,
Foster City, CA, USA) using the ‘Folmer’ universal primers
and according to published cycling conditions [18]; all
products were visualised on 1% agarose gel stained with
GelRed™(Hayward, CA, USA). The amplification reactions
were done in 25 μl total volume, with 2.5 μlM g C l 2 (20
MM concentration), 2.5 μl 5 × buffer, 2.5 μlp r e - m i x e d
dNTPs (20 MM concentration), 1 μl each of forward and
reverse primer (10 pmol concentration) and one unit of
TAQ per reaction. The 22 successfully amplified PCR pro-
ducts were purified using a QIAQuick PCR Purification
Kit (QIAGEN Ltd, Crawley, UK) and product concentra-
tion was quantified on a Nanodrop ND-1000 Spectrophot-
ometer (Nanodrop Technologies Inc., Willington, USA).
Sequencing reactions were performed on mitochondrial
purified PCR products using an Applied Biosystems Big
Dye Kit (version 1.1) and run on an Applied Biosystems
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Sequences were assembled and edited by eye using
Sequencher v 4.8 (Gene Codes Corporation, Ann Arbor,
Michigan, USA: http://www.genecodes.com); 9 double-
s t r a n d e ds e q u e n c e sw e r ea b l et ob ee d i t e dc l e a r l ya n d
these were used in later analysis. Distance calculations
were performed in MEGA 4.0 [19].
Parasitological surveys
In total, 1014 children were sampled from 61 localities
across the Sesse Islands (Kalangala district). 514 were
male and 500 were female, and the mean age was
9.5 years (see below for details of data cleaning prior to
analysis). 45 sites (numbered on Figure 1a) were
sampled using both Kato-Katz thick double smears,
from a single stool, and CCA urine lateral flow tests
(Rapid Medical Diagnostics, Pretoria, South Africa). As
an alternative arbitration of diagnostic results, at 5 of
these sites (Figure 1b) children were also tested on site
for antibodies against soluble egg antigens using SEA-
ELISA kits (IVD Inc.; Carlsbad, USA) with sera collected
from fingerprick blood and processed according to kit
instructions. GPS coordinates were also recorded for
each parasitological survey location (as above).
Sample collection and preparation
Stool and urine samples were collected with the assis-
tance of local community health officers, mobilisers and
Vector Control Division technicians. Finger-prick blood
was collected by a trained community nurse, and con-
sumables disposed of immediately following the SEA-
ELISA tests. Approximately 0.5 mol of finger-prick
blood was centrifuged to separate out the serum; this
was used in the SEA-ELISA test at a dilution of 1:40 (as
per the manufacturer’s instructions).
Stool samples were used to prepare a duplicate Kato-
Katz thick smear on a single microscope slide, as per
standard methods [20]. These slides were read in situ
after a clearing period of approximately 30 min and
counted for S. mansoni eggs. Slides were later cross-
checked in the laboratory. Approximately 15 μlo fu r i n e
was used for each CCA urine lateral flow test, which
was read on the spot after the prescribed incubation
time and cross-checked by another observer. Results
were recorded as ‘negative’, ‘trace’, ‘single positive’, ‘dou-
ble positive’ and ‘triple positive’.
Data analysis
Prior to analysis, the raw dataset was cleaned to remove
any children whose reported age was greater than 15.
Prevalence estimates and 95% CI were calculated using
version 2.8.0 of the R statistical package [21], along with
all statistical modelling.
Ethical approvals
The parents or guardians (head teachers) of all partici-
pating children were asked to sign written consent
forms prior to their child’s inclusion in the survey; in
addition, each child was individually asked for oral con-
sent. Each child was treated with praziquantel (40 mg/
kg) and albendazole (400 mg) by the community nurse
after taking part in the study.
Ethical clearance for this study was granted by the
National Health System Local Research Ethics Commit-
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